Drugs / Cinitapride
Cinitapride
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01355276 | Oct 2010 → Jun 2011 | dyspepsia | Eisai Inc. | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cinitapride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01355276 ↗ |
| Known as | Cinitaprida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104523 ↗ |
| Known as | Paxapride | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104523 ↗ |
| Modality | Small molecule | — CHEMBL2104523 ↗ |